Wilmington, DE, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced the sale of its ...
Enovis, the medical technology company, just completed the sale of its Dr. Comfort diabetic footwear segment to Promus Equity Partners. This strategic move is intended to sharpen Enovis’ focus on its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results